BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1376203 COc1nc2c(-c3cn[nH]c3)c(-c3nnc([nH]3)C(F)(F)F)n(C)c2cc1Cl InChI=1S/C15H11ClF3N7O/c1-26-8-3-7(16)13(27-2)22-10(8)9(6-4-20-21-5-6)11(26)12-23-14(25-24-12)15(17,18)19/h3-5H,1-2H3,(H,20,21)(H,23,24,25) YMEKLMUAVZZCGV-UHFFFAOYSA-N 651789 US20240051954, Example 1::6-chloro-5-methoxy-1-methyl- 3-(1H-pyrazol-4-yl)-2-(5- (trifluoromethyl)-4H-1,2,4- triazol-3-yl)-1H-pyrrolo[3,2- b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 76.0 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651789 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651789&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362539 494495947 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376204 COc1nc2c(-c3cn[nH]c3)c(-c3nnc([nH]3)C(C)(F)F)n(C)c2cc1Cl InChI=1S/C16H14ClF2N7O/c1-16(18,19)15-23-13(24-25-15)12-10(7-5-20-21-6-7)11-9(26(12)2)4-8(17)14(22-11)27-3/h4-6H,1-3H3,(H,20,21)(H,23,24,25) CAVXEEPSRGVUNO-UHFFFAOYSA-N 651790 US20240051954, Example 2::6-chloro-2-(5-(1,1-difluoro- ethyl)-4H-1,2,4-triazol-3-yl)- 5-methoxy-1-methyl-3-(1H- pyrazol-4-yl)-1H-pyrrolo[3,2- b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 124 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651790 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651790&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362540 494495948 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376205 COc1nc2c(-c3cn[nH]c3)c([nH]c2cc1Cl)-c1nnc([nH]1)C(C)(F)F InChI=1S/C15H12ClF2N7O/c1-15(17,18)14-23-12(24-25-14)11-9(6-4-19-20-5-6)10-8(21-11)3-7(16)13(22-10)26-2/h3-5,21H,1-2H3,(H,19,20)(H,23,24,25) MHGBRJPBEHLZPE-UHFFFAOYSA-N 651791 US20240051954, Example 3::6-chloro-2-(5-(1,1-difluoro- ethyl)-4H-1,2,4-triazol-3-yl)- 5-methoxy-3-(1H-pyrazol-4- yl)-1H-pyrrolo[3,2-b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 32.0 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651791 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651791&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362541 494495949 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376206 COc1nc2c(-c3cn[nH]c3)c(-c3nnc(CF)[nH]3)n(C)c2cc1Cl InChI=1S/C15H13ClFN7O/c1-24-9-3-8(16)15(25-2)21-12(9)11(7-5-18-19-6-7)13(24)14-20-10(4-17)22-23-14/h3,5-6H,4H2,1-2H3,(H,18,19)(H,20,22,23) RIISDKTZUDDEND-UHFFFAOYSA-N 651792 US20240051954, Example 4::6-chloro-2-(5-(fluoromethyl)- 4H-1,2,4-triazol-3-yl)-5- methoxy-1-methyl-3-(1H- pyrazol-4-yl)-1H-pyrrolo[3,2- b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 335 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651792 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651792&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362542 494495950 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376207 COc1nc2c(-c3cn[nH]c3)c([nH]c2cc1Cl)-c1nnc([nH]1)C(F)(F)CO InChI=1S/C15H12ClF2N7O2/c1-27-13-7(16)2-8-10(22-13)9(6-3-19-20-4-6)11(21-8)12-23-14(25-24-12)15(17,18)5-26/h2-4,21,26H,5H2,1H3,(H,19,20)(H,23,24,25) PNMIYCICTONDSG-UHFFFAOYSA-N 651793 US20240051954, Example 5::2-(5-(6-chloro-5-methoxy-3- (1H-pyrazol-4-yl)-1H- pyrrolo[3,2-b]pyridin-2-yl)- 4H-1,2,4-triazol-3-yl)-2,2- difluoroethan-1-ol Cyclic GMP-AMP synthase [147-522] Homo sapiens 97.0 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651793 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651793&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362543 494495951 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376208 COc1nc2c(-c3cn[nH]c3)c([nH]c2cc1Cl)-c1nnc([nH]1)C(C)=O InChI=1S/C15H12ClN7O2/c1-6(24)13-21-14(23-22-13)12-10(7-4-17-18-5-7)11-9(19-12)3-8(16)15(20-11)25-2/h3-5,19H,1-2H3,(H,17,18)(H,21,22,23) PGHMGKRVOOCTHU-UHFFFAOYSA-N 651794 US20240051954, Example 6::1-(5-(6-chloro-5-methoxy-3- (1H-pyrazol-4-yl)-1H- pyrrolo[3,2-b]pyridin-2-yl)- 4H-1,2,4-triazol-3-yl)ethan- 1-one Cyclic GMP-AMP synthase [147-522] Homo sapiens 66.0 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651794 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651794&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362544 494495952 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376209 COc1nc2c(-c3cn[nH]c3)c(-c3nnc(CO)[nH]3)n(C)c2cc1Cl InChI=1S/C15H14ClN7O2/c1-23-9-3-8(16)15(25-2)20-12(9)11(7-4-17-18-5-7)13(23)14-19-10(6-24)21-22-14/h3-5,24H,6H2,1-2H3,(H,17,18)(H,19,21,22) KWFCQNNJHCCXIK-UHFFFAOYSA-N 651795 US20240051954, Example 7::(5-(6-chloro-5-methoxy-1- methyl-3-(1H-pyrazol-4-yl)- 1H-pyrrolo[3,2-b]pyridin-2- yl)-4H-1,2,4-triazol-3-yl)- methanol Cyclic GMP-AMP synthase [147-522] Homo sapiens 756 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651795 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651795&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362545 494495953 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376210 COCC(F)(F)c1nnc([nH]1)-c1c(-c2cn[nH]c2)c2nc(OC)c(Cl)cc2n1C InChI=1S/C17H16ClF2N7O2/c1-27-10-4-9(18)15(29-3)23-12(10)11(8-5-21-22-6-8)13(27)14-24-16(26-25-14)17(19,20)7-28-2/h4-6H,7H2,1-3H3,(H,21,22)(H,24,25,26) PINMCERGZMOXMK-UHFFFAOYSA-N 651796 US20240051954, Example 8::6-chloro-2-(5-(1,1-difluoro-2- methoxyethyl)-4H-1,2,4- triazol-3-yl)-5-methoxy-1- methyl-3-(1H-pyrazol-4-yl)- 1H-pyrrolo[3,2-b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 55.0 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651796 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651796&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362546 494495954 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376211 COc1nc2c(-c3cn[nH]c3)c(-c3nnc(F)[nH]3)n(C)c2cc1Cl InChI=1S/C14H11ClFN7O/c1-23-8-3-7(15)13(24-2)19-10(8)9(6-4-17-18-5-6)11(23)12-20-14(16)22-21-12/h3-5H,1-2H3,(H,17,18)(H,20,21,22) YCLBDQNXYXETRC-UHFFFAOYSA-N 651797 US20240051954, Example 9::6-chloro-2-(5-fluoro-4H- 1,2,4-triazol-3-yl)-5-methoxy- 1-methyl-3-(1H-pyrazol-4- yl)-1H-pyrrolo[3,2-b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 267 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651797 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651797&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362547 494495955 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376212 COc1nc2c(-c3cn[nH]c3)c([nH]c2cc1Cl)-c1nnc(F)[nH]1 InChI=1S/C13H9ClFN7O/c1-23-12-6(14)2-7-9(19-12)8(5-3-16-17-4-5)10(18-7)11-20-13(15)22-21-11/h2-4,18H,1H3,(H,16,17)(H,20,21,22) SSMGRWSBUYBXMZ-UHFFFAOYSA-N 651798 US20240051954, Example 10::6-chloro-2-(5-fluoro-4H- 1,2,4-triazol-3-yl)-5-methoxy- 3-(1H-pyrazol-4-yl)-1H- pyrrolo[3,2-b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 63.0 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651798 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651798&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362548 494495956 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376213 COCc1nnc([nH]1)-c1c(-c2cn[nH]c2)c2nc(OC)c(Cl)cc2n1C InChI=1S/C16H16ClN7O2/c1-24-10-4-9(17)16(26-3)21-13(10)12(8-5-18-19-6-8)14(24)15-20-11(7-25-2)22-23-15/h4-6H,7H2,1-3H3,(H,18,19)(H,20,22,23) VJISHYQZJMSYRU-UHFFFAOYSA-N 651799 US20240051954, Example 11::6-chloro-5-methoxy-2-(5- (methoxymethyl)-4H-1,2,4- triazol-3-yl)-1-methyl-3-(1H- pyrazol-4-yl)-1H-pyrrolo[3,2- b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 155 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651799 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651799&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362549 494495957 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376214 COc1nnc([nH]1)-c1[nH]c2cc(Cl)c(OC)nc2c1-c1cn[nH]c1 InChI=1S/C14H12ClN7O2/c1-23-13-7(15)3-8-10(19-13)9(6-4-16-17-5-6)11(18-8)12-20-14(24-2)22-21-12/h3-5,18H,1-2H3,(H,16,17)(H,20,21,22) CQGGIZNHQZXSAN-UHFFFAOYSA-N 651800 US20240051954, Example 12::6-chloro-5-methoxy-2-(5- methoxy-4H-1,2,4-triazol-3- yl)-3-(1H-pyrazol-4-yl)-1H- pyrrolo[3,2-b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 333 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651800 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651800&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362550 494495958 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376215 COc1nc2c(-c3cn[nH]c3)c([nH]c2cc1Cl)-c1nnc(Cl)[nH]1 InChI=1S/C13H9Cl2N7O/c1-23-12-6(14)2-7-9(19-12)8(5-3-16-17-4-5)10(18-7)11-20-13(15)22-21-11/h2-4,18H,1H3,(H,16,17)(H,20,21,22) HNYALLOJMUXDKH-UHFFFAOYSA-N 651801 US20240051954, Example 13::6-chloro-2-(5-chloro-4H- 1,2,4-triazol-3-yl)-5-methoxy- 3-(1H-pyrazol-4-yl)-1H- pyrrolo[3,2-b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 122 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651801 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651801&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362551 494495959 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376216 COc1nc2c(-c3cn[nH]c3)c(-c3nnc[nH]3)n(C)c2cc1Cl InChI=1S/C14H12ClN7O/c1-22-9-3-8(15)14(23-2)20-11(9)10(7-4-17-18-5-7)12(22)13-16-6-19-21-13/h3-6H,1-2H3,(H,17,18)(H,16,19,21) XQWLYYFRFSFUDO-UHFFFAOYSA-N 651802 US20240051954, Example 14::6-chloro-5-methoxy-1-methyl- 3-(1H-pyrazol-4-yl)-2-(4H- 1,2,4-triazol-3-yl)-1H- pyrrolo[3,2-b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 3520 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651802 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651802&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362552 494495960 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376217 COCC(F)(F)c1nnc([nH]1)-c1[nH]c2cc(Cl)c(OC)nc2c1-c1cn[nH]c1 InChI=1S/C16H14ClF2N7O2/c1-27-6-16(18,19)15-24-13(25-26-15)12-10(7-4-20-21-5-7)11-9(22-12)3-8(17)14(23-11)28-2/h3-5,22H,6H2,1-2H3,(H,20,21)(H,24,25,26) BIJKKPBBYDEQSD-UHFFFAOYSA-N 651803 US20240051954, Example 15::6-chloro-2-(5-(1,1-difluoro-2- methoxyethyl)-4H-1,2,4- triazol-3-yl)-5-methoxy-3- (1H-pyrazol-4-yl)-1H- pyrrolo[3,2-b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 30.0 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651803 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651803&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362553 494495961 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376218 COc1nc2c(-c3cn[nH]c3)c([nH]c2cc1Cl)-c1nnc([nH]1)C(=O)N(C)C InChI=1S/C16H15ClN8O2/c1-25(2)16(26)14-22-13(23-24-14)12-10(7-5-18-19-6-7)11-9(20-12)4-8(17)15(21-11)27-3/h4-6,20H,1-3H3,(H,18,19)(H,22,23,24) AYYWSFFVYZXQCZ-UHFFFAOYSA-N 651804 US20240051954, Example 16::5-(6-chloro-5-methoxy-3-(1H- pyrazol-4-yl)-1H-pyrrolo[3,2- b]pyridin-2-yl)-N,N-dimethyl- 4H-1,2,4-triazole-3- carboxamide Cyclic GMP-AMP synthase [147-522] Homo sapiens 30.0 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651804 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651804&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362554 494495962 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376219 COc1nc2c(c(-c3nnc([nH]3)C(=O)N(C)C)n(C)c2cc1Cl)-n1ccnc1 InChI=1S/C17H17ClN8O2/c1-24(2)17(27)15-21-14(22-23-15)13-12(26-6-5-19-8-26)11-10(25(13)3)7-9(18)16(20-11)28-4/h5-8H,1-4H3,(H,21,22,23) HHFPJCNIQQCMIB-UHFFFAOYSA-N 651805 US20240051954, Example 17::5-(6-chloro-3-(1H-imidazol-1- yl)-5-methoxy-1-methyl-1H- pyrrolo[3,2-b]pyridin-2-yl)- N,N-dimethyl-4H-1,2,4- triazole-3-carboxamide Cyclic GMP-AMP synthase [147-522] Homo sapiens 116 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651805 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651805&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549017 494495963 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376220 COc1nc2c(c(-c3nnc([nH]3)N3CCCC3=O)n(C)c2cc1Cl)-n1ccnc1 InChI=1S/C18H17ClN8O2/c1-25-11-8-10(19)17(29-2)21-13(11)14(26-7-5-20-9-26)15(25)16-22-18(24-23-16)27-6-3-4-12(27)28/h5,7-9H,3-4,6H2,1-2H3,(H,22,23,24) AAMZREWTXLTFHN-UHFFFAOYSA-N 651806 US20240051954, Example 18::1-(5-(6-chloro-3-(1H-imidazol- 1-yl)-5-methoxy-1-methyl-1H- pyrrolo[3,2-b]pyridin-2-yl)- 4H-1,2,4-triazol-3-yl)pyrroli- din-2-one Cyclic GMP-AMP synthase [147-522] Homo sapiens 258 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651806 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651806&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549087 494495964 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376221 COc1nc2c(c(-c3nnc([nH]3)N(C)C)n(C)c2cc1Cl)-n1ccnc1 InChI=1S/C16H17ClN8O/c1-23(2)16-20-14(21-22-16)13-12(25-6-5-18-8-25)11-10(24(13)3)7-9(17)15(19-11)26-4/h5-8H,1-4H3,(H,20,21,22) VCBZSGOTKLYMPM-UHFFFAOYSA-N 651807 US20240051954, Example 19::5-(6-chloro-3-(1H-imidazol-1- yl)-5-methoxy-1-methyl-1H- pyrrolo[3,2-b]pyridin-2-yl)- N,N-dimethyl-4H-1,2,4- triazol-3-amine Cyclic GMP-AMP synthase [147-522] Homo sapiens 289 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651807 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651807&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549068 494495965 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376222 CNc1nnc([nH]1)-c1c(-n2ccnc2)c2nc(OC)c(Cl)cc2n1C InChI=1S/C15H15ClN8O/c1-17-15-20-13(21-22-15)12-11(24-5-4-18-7-24)10-9(23(12)2)6-8(16)14(19-10)25-3/h4-7H,1-3H3,(H2,17,20,21,22) ONFXRXVUTHMXPG-UHFFFAOYSA-N 651808 US20240051954, Example 20::5-(6-chloro-3-(1H-imidazol-1- yl)-5-methoxy-1-methyl-1H- pyrrolo[3,2-b]pyridin-2-yl)-N- methyl-4H-1,2,4-triazol-3- amine Cyclic GMP-AMP synthase [147-522] Homo sapiens 824 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651808 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651808&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549101 494495966 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376223 COc1nc2c(c(-c3nnc([nH]3)C(O)C(F)F)n(C)c2cc1Cl)-n1ccnc1 InChI=1S/C16H14ClF2N7O2/c1-25-8-5-7(17)16(28-2)21-9(8)10(26-4-3-20-6-26)11(25)14-22-15(24-23-14)12(27)13(18)19/h3-6,12-13,27H,1-2H3,(H,22,23,24) MGZGAGDHZNCSSR-UHFFFAOYSA-N 651809 US20240051954, Example 21::1-(5-(6-chloro-3-(1H-imidazol- 1-yl)-5-methoxy-1-methyl-1H- pyrrolo[3,2-b]pyridin-2-yl)- 4H-1,2,4-triazol-3-yl)-2,2- difluoroethan-1-ol Cyclic GMP-AMP synthase [147-522] Homo sapiens 121 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651809 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651809&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549094 494495967 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376224 COC(C(F)F)c1nnc([nH]1)-c1c(-n2ccnc2)c2nc(OC)c(Cl)cc2n1C InChI=1S/C17H16ClF2N7O2/c1-26-9-6-8(18)17(29-3)22-10(9)11(27-5-4-21-7-27)12(26)15-23-16(25-24-15)13(28-2)14(19)20/h4-7,13-14H,1-3H3,(H,23,24,25) GMZUYQRBDMRXRH-UHFFFAOYSA-N 651810 US20240051954, Example 22::6-chloro-2-(5-(2,2-difluoro-1- methoxyethyl)-4H-1,2,4- triazol-3-yl)-3-(1H-imidazol- 1-yl)-5-methoxy-1-methyl- 1H-pyrrolo[3,2-b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 93.0 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651810 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651810&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549037 494495968 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376225 COCC(OC)c1nnc([nH]1)-c1c(-n2ccnc2)c2nc(OC)c(Cl)cc2n1C InChI=1S/C18H20ClN7O3/c1-25-11-7-10(19)18(29-4)21-13(11)14(26-6-5-20-9-26)15(25)17-22-16(23-24-17)12(28-3)8-27-2/h5-7,9,12H,8H2,1-4H3,(H,22,23,24) XXJXQMIDGVIYGY-UHFFFAOYSA-N 651811 US20240051954, Example 23::6-chloro-2-(5-(1,2-dimethoxy- ethyl)-4H-1,2,4-triazol-3-yl)- 3-(1H-imidazol-1-yl)-5-meth- oxy-1-methyl-1H-pyrrolo- [3,2-b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 144 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651811 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651811&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549013 494495969 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376226 COc1nc2c(c(-c3nnc([nH]3)C(OCCO)C(F)(F)F)n(C)c2cc1Cl)-n1ccnc1 InChI=1S/C18H17ClF3N7O3/c1-28-10-7-9(19)17(31-2)24-11(10)12(29-4-3-23-8-29)13(28)15-25-16(27-26-15)14(18(20,21)22)32-6-5-30/h3-4,7-8,14,30H,5-6H2,1-2H3,(H,25,26,27) DDKDQYWSWUXZOX-UHFFFAOYSA-N 651812 US20240051954, Example 24::2-(1-(5-(6-chloro-3-(1H- imidazol-1-yl)-5-methoxy-1- methyl-1H-pyrrolo[3,2-b]- pyridin-2-yl)-4H-1,2,4-triazol- 3-yl)-2,2,2-trifluoroethoxy)- ethan-1-ol Cyclic GMP-AMP synthase [147-522] Homo sapiens 114 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651812 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651812&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549022 494495970 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376227 COc1nc2c(c(-c3nnc([nH]3)C(C)O)n(C)c2cc1Cl)-n1ccnc1 InChI=1S/C16H16ClN7O2/c1-8(25)14-20-15(22-21-14)13-12(24-5-4-18-7-24)11-10(23(13)2)6-9(17)16(19-11)26-3/h4-8,25H,1-3H3,(H,20,21,22) GTKMMYUCFPEQAR-UHFFFAOYSA-N 651813 US20240051954, Example 25::1-(5-(6-chloro-3-(1H-imidazol- 1-yl)-5-methoxy-1-methyl-1H- pyrrolo[3,2-b]pyridin-2-yl)-4H- 1,2,4-triazol-3-yl)ethan-1-ol Cyclic GMP-AMP synthase [147-522] Homo sapiens 369 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651813 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651813&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549070 494495971 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376228 COC(c1nnc([nH]1)-c1c(-n2ccnc2)c2nc(OC)c(Cl)cc2n1C)C(F)(F)F InChI=1S/C17H15ClF3N7O2/c1-27-9-6-8(18)16(30-3)23-10(9)11(28-5-4-22-7-28)12(27)14-24-15(26-25-14)13(29-2)17(19,20)21/h4-7,13H,1-3H3,(H,24,25,26) CMYPHCXNNMEUNM-UHFFFAOYSA-N 651814 US20240051954, Example 26::6-chloro-3-(1H-imidazol-1-yl)- 5-methoxy-1-methyl-2-(5- (2,2,2-trifluoro-1-methoxy- ethyl)-4H-1,2,4-triazol-3-yl)- 1H-pyrrolo[3,2-b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 107 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651814 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651814&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549056 494495972 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376229 COc1nc2c(c(-c3nnc([nH]3)C(F)(F)CO)n(C)c2cc1Cl)-n1ccnc1 InChI=1S/C16H14ClF2N7O2/c1-25-9-5-8(17)14(28-2)21-10(9)11(26-4-3-20-7-26)12(25)13-22-15(24-23-13)16(18,19)6-27/h3-5,7,27H,6H2,1-2H3,(H,22,23,24) WBBWKWAMJWZSOJ-UHFFFAOYSA-N 651815 US20240051954, Example 27::2-(5-(6-chloro-3-(1H-imidazol- 1-yl)-5-methoxy-1-methyl-1H- pyrrolo[3,2-b]pyridin-2-yl)-4H- 1,2,4-triazol-3-yl)-2,2-difluoro- ethan-1-ol Cyclic GMP-AMP synthase [147-522] Homo sapiens 45.0 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651815 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651815&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549077 494495973 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376230 COc1nc2c(c(-c3nnc([nH]3)C(O)C(F)(F)F)n(C)c2cc1Cl)-n1ccnc1 InChI=1S/C16H13ClF3N7O2/c1-26-8-5-7(17)15(29-2)22-9(8)10(27-4-3-21-6-27)11(26)13-23-14(25-24-13)12(28)16(18,19)20/h3-6,12,28H,1-2H3,(H,23,24,25) JQJWTOGXIOWLJX-UHFFFAOYSA-N 651816 US20240051954, Example 28::1-(5-(6-chloro-3-(1H-imidazol- 1-yl)-5-methoxy-1-methyl-1H- pyrrolo[3,2-b]pyridin-2-yl)-4H- 1,2,4-triazol-3-yl)-2,2,2- trifluoroethan-1-ol Cyclic GMP-AMP synthase [147-522] Homo sapiens 61.0 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651816 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651816&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549041 494495974 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376231 COCC(O)c1nnc([nH]1)-c1c(-n2ccnc2)c2nc(OC)c(Cl)cc2n1C InChI=1S/C17H18ClN7O3/c1-24-10-6-9(18)17(28-3)20-12(10)13(25-5-4-19-8-25)14(24)16-21-15(22-23-16)11(26)7-27-2/h4-6,8,11,26H,7H2,1-3H3,(H,21,22,23) BBWPUZHJKVPMHY-UHFFFAOYSA-N 651817 US20240051954, Example 29::1-(5-(6-chloro-3-(1H-imidazol- 1-yl)-5-methoxy-1-methyl-1H- pyrrolo[3,2-b]pyridin-2-yl)-4H- 1,2,4-triazol-3-yl)-2-methoxy- ethan-1-ol Cyclic GMP-AMP synthase [147-522] Homo sapiens 295 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651817 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651817&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549039 494495975 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376232 COCC(F)(F)c1nnc([nH]1)-c1c(-n2ccnc2)c2nc(OC)c(Cl)cc2n1C InChI=1S/C17H16ClF2N7O2/c1-26-10-6-9(18)15(29-3)22-11(10)12(27-5-4-21-8-27)13(26)14-23-16(25-24-14)17(19,20)7-28-2/h4-6,8H,7H2,1-3H3,(H,23,24,25) QIVLFPNOXNOEGT-UHFFFAOYSA-N 651818 US20240051954, Example 30::6-chloro-2-(5-(1,1-difluoro-2- methoxyethyl)-4H-1,2,4-triazol- 3-yl)-3-(1H-imidazol-1-yl)-5- methoxy-1-methyl-1H-pyrrolo- [3,2-b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 186 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651818 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651818&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549035 494495976 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376233 COc1nc2c(c(-c3nnc([nH]3)C(C)(F)F)n(C)c2cc1Cl)-n1ccnc1 InChI=1S/C16H14ClF2N7O/c1-16(18,19)15-22-13(23-24-15)12-11(26-5-4-20-7-26)10-9(25(12)2)6-8(17)14(21-10)27-3/h4-7H,1-3H3,(H,22,23,24) ZZWABLKXVISVEO-UHFFFAOYSA-N 651819 US20240051954, Example 31::6-chloro-2-(5-(1,1-difluoro- ethyl)-4H-1,2,4-triazol-3-yl)- 3-(1H-imidazol-1-yl)-5-meth- oxy-1-methyl-1H-pyrrolo- [3,2-b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 79.0 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651819 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651819&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549110 494495977 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376234 COc1nc2c(c(-c3nnc([nH]3)C(C)=O)n(C)c2cc1Cl)-n1ccnc1 InChI=1S/C16H14ClN7O2/c1-8(25)14-20-15(22-21-14)13-12(24-5-4-18-7-24)11-10(23(13)2)6-9(17)16(19-11)26-3/h4-7H,1-3H3,(H,20,21,22) DAHKPCVQTDHFPP-UHFFFAOYSA-N 651820 US20240051954, Example 32::1-(5-(6-chloro-3-(1H-imidazol- 1-yl)-5-methoxy-1-methyl-1H- pyrrolo[3,2-b]pyridin-2-yl)-4H- 1,2,4-triazol-3-yl)ethan-1-one Cyclic GMP-AMP synthase [147-522] Homo sapiens 188 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651820 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651820&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164548998 494495978 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376235 COc1nc2c(c(-c3nnc(F)[nH]3)n(C)c2cc1Cl)-n1ccnc1 InChI=1S/C14H11ClFN7O/c1-22-8-5-7(15)13(24-2)18-9(8)10(23-4-3-17-6-23)11(22)12-19-14(16)21-20-12/h3-6H,1-2H3,(H,19,20,21) RZWLEFUGFDVWFJ-UHFFFAOYSA-N 651821 US20240051954, Example 33::6-chloro-2-(5-fluoro-4H-1,2,4- triazol-3-yl)-3-(1H-imidazol-1- yl)-5-methoxy-1-methyl-1H- pyrrolo[3,2-b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 332 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651821 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651821&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549019 494495979 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376236 COc1nc2c(c(-c3nnc([nH]3)C(C)C#N)n(C)c2cc1Cl)-n1ccnc1 InChI=1S/C17H15ClN8O/c1-9(7-19)15-22-16(24-23-15)14-13(26-5-4-20-8-26)12-11(25(14)2)6-10(18)17(21-12)27-3/h4-6,8-9H,1-3H3,(H,22,23,24) UHYGTUGQHGKOIW-UHFFFAOYSA-N 651822 US20240051954, Example 34::2-(5-(6-chloro-3-(1H-imidazol- 1-yl)-5-methoxy-1-methyl-1H- pyrrolo[3,2-b]pyridin-2-yl)- 4H-1,2,4-triazol-3-yl)propane- nitrile Cyclic GMP-AMP synthase [147-522] Homo sapiens 54.0 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651822 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651822&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164548999 494495980 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376237 COc1nc2c(c(-c3nnc[nH]3)n(C)c2cc1Cl)-n1ccnc1 InChI=1S/C14H12ClN7O/c1-21-9-5-8(15)14(23-2)19-10(9)11(22-4-3-16-7-22)12(21)13-17-6-18-20-13/h3-7H,1-2H3,(H,17,18,20) LYJPZVHUKGVZQV-UHFFFAOYSA-N 651823 US20240051954, Example 35::6-chloro-3-(1H-imidazol-1- yl)-5-methoxy-1-methyl-2-(4H- 1,2,4-triazol-3-yl)-1H-pyrrolo- [3,2-b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 4065 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651823 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651823&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549105 494495981 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376238 COCC(N(C)C)c1nnc([nH]1)-c1c(-n2ccnc2)c2nc(OC)c(Cl)cc2n1C InChI=1S/C19H23ClN8O2/c1-26(2)13(9-29-4)17-23-18(25-24-17)16-15(28-7-6-21-10-28)14-12(27(16)3)8-11(20)19(22-14)30-5/h6-8,10,13H,9H2,1-5H3,(H,23,24,25) MWPARRJTVPHFFJ-UHFFFAOYSA-N 651824 US20240051954, Example 36::1-(5-(6-chloro-3-(1H-imidazol- 1-yl)-5-methoxy-1-methyl- 1H-pyrrolo[3,2-b]pyridin-2-yl)- 4H-1,2,4-triazol-3-yl)-2-meth- oxy-N,N-dimethylethan-1-amine Cyclic GMP-AMP synthase [147-522] Homo sapiens 454 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651824 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651824&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164548997 494495982 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376239 COCC(c4nnc(c3c(n1cnnc1)c2nc(OC)c(Cl)cc2n3C)[nH]4)N(C)C InChI=1S/C18H22ClN9O2/c1-26(2)12(7-29-4)16-23-17(25-24-16)15-14(28-8-20-21-9-28)13-11(27(15)3)6-10(19)18(22-13)30-5/h6,8-9,12H,7H2,1-5H3,(H,23,24,25) YLASXQOCLQCJLW-UHFFFAOYSA-N 651825 US20240051954, Example 37::1-(5-(6-chloro-5-methoxy-1- methyl-3-(1H-pyrazol-4-yl)- 1H-pyrrolo[3,2-b]pyridin-2- yl)-4H-1,2,4-triazol-3-yl)-2- methoxy-N,N-dimethylethan- 1-amine Cyclic GMP-AMP synthase [147-522] Homo sapiens 123 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651825 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651825&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 175679472 494495983 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376240 COc1nc2c(c(-c3nnc([nH]3)C(C)N(C)C)n(C)c2cc1Cl)-n1ccnc1 InChI=1S/C18H21ClN8O/c1-10(25(2)3)16-22-17(24-23-16)15-14(27-7-6-20-9-27)13-12(26(15)4)8-11(19)18(21-13)28-5/h6-10H,1-5H3,(H,22,23,24) RVGWXBZTHPWQTP-UHFFFAOYSA-N 651826 US20240051954, Example 38::1-(5-(6-chloro-3-(1H-imidazol- 1-yl)-5-methoxy-1-methyl-1H- pyrrolo[3,2-b]pyridin-2-yl)- 4H-1,2,4-triazol-3-yl)-N,N- dimethylethan-1-amine Cyclic GMP-AMP synthase [147-522] Homo sapiens 335 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651826 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651826&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549062 494495984 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376241 CO\N=C(/C)c1nnc([nH]1)-c1c(-n2ccnc2)c2nc(OC)c(Cl)cc2n1C InChI=1S/C17H17ClN8O2/c1-9(24-28-4)15-21-16(23-22-15)14-13(26-6-5-19-8-26)12-11(25(14)2)7-10(18)17(20-12)27-3/h5-8H,1-4H3,(H,21,22,23) WZNNWXLQWUVZLZ-UHFFFAOYSA-N 651827 US20240051954, Example 39::(E)-1-(5-(6-chloro-3-(1H- imidazol-1-yl)-5-methoxy-1- methyl-1H-pyrrolo[3,2-b]- pyridin-2-yl)-4H-1,2,4-triazol- 3-yl)ethan-1-one O-methyl oxime Cyclic GMP-AMP synthase [147-522] Homo sapiens 252 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651827 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651827&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549007 494495985 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376242 COc1nc2c(c(-c3nnc([nH]3)C(\C)=N\OCCO)n(C)c2cc1Cl)-n1ccnc1 InChI=1S/C18H19ClN8O3/c1-10(25-30-7-6-28)16-22-17(24-23-16)15-14(27-5-4-20-9-27)13-12(26(15)2)8-11(19)18(21-13)29-3/h4-5,8-9,28H,6-7H2,1-3H3,(H,22,23,24) MDMXPDHZCDCOQC-UHFFFAOYSA-N 651828 US20240051954, Example 40::(E)-1-(5-(6-chloro-3-(1H- imidazol-1-yl)-5-methoxy-1- methyl-1H-pyrrolo[3,2-b]- pyridin-2-yl)-4H-1,2,4-triazol- 3-yl)ethan-1-one O-(2-hydroxy- ethyl) oxime Cyclic GMP-AMP synthase [147-522] Homo sapiens 101 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651828 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651828&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549002 494495986 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376243 COC(c1nnc([nH]1)-c1c(-c2cn[nH]c2)c2nc(OC)c(Cl)cc2n1C)C(F)(F)F InChI=1S/C17H15ClF3N7O2/c1-28-9-4-8(18)16(30-3)24-11(9)10(7-5-22-23-6-7)12(28)14-25-15(27-26-14)13(29-2)17(19,20)21/h4-6,13H,1-3H3,(H,22,23)(H,25,26,27) KLNHQEQEOOEXFN-UHFFFAOYSA-N 651829 US20240051954, Example 41::6-chloro-5-methoxy-1-methyl- 3-(1H-pyrazol-4-yl)-2-(5- (2,2,2-trifluoro-1-methoxy- ethyl)-4H-1,2,4-triazol-3-yl)- 1H-pyrrolo[3,2-b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 67.0 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651829 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651829&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362555 494495987 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376244 COc1nc2c(-c3cn[nH]c3)c(-c3nnc([nH]3)C(C)=O)n(C)c2cc1Cl InChI=1S/C16H14ClN7O2/c1-7(25)14-21-15(23-22-14)13-11(8-5-18-19-6-8)12-10(24(13)2)4-9(17)16(20-12)26-3/h4-6H,1-3H3,(H,18,19)(H,21,22,23) RJCWJWLROIGDDS-UHFFFAOYSA-N 651830 US20240051954, Example 42::1-(5-(6-chloro-5-methoxy-1- methyl-3-(1H-pyrazol-4-yl)- 1H-pyrrolo[3,2-b]pyridin-2- yl)-4H-1,2,4-triazol-3-yl)ethan- 1-one Cyclic GMP-AMP synthase [147-522] Homo sapiens 66.0 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651830 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651830&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362556 494495988 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376245 COc1nc2c(-c3cn[nH]c3)c(-c3nnc([nH]3)C(=O)N(C)C)n(C)c2cc1Cl InChI=1S/C17H17ClN8O2/c1-25(2)17(27)15-22-14(23-24-15)13-11(8-6-19-20-7-8)12-10(26(13)3)5-9(18)16(21-12)28-4/h5-7H,1-4H3,(H,19,20)(H,22,23,24) AEKTXGAMGYUAHR-UHFFFAOYSA-N 651831 US20240051954, Example 43::5-(6-chloro-5-methoxy-1-meth- yl-3-(1H-pyrazol-4-yl)-1H- pyrrolo[3,2-b]pyridin-2-yl)- N,N-dimethyl-4H-1,2,4- triazole-3-carboxamide Cyclic GMP-AMP synthase [147-522] Homo sapiens 98.0 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651831 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651831&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362557 494495989 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376246 COCC(OC)c1nnc([nH]1)-c1c(-c2cn[nH]c2)c2nc(OC)c(Cl)cc2n1C InChI=1S/C18H20ClN7O3/c1-26-11-5-10(19)18(29-4)22-14(11)13(9-6-20-21-7-9)15(26)17-23-16(24-25-17)12(28-3)8-27-2/h5-7,12H,8H2,1-4H3,(H,20,21)(H,23,24,25) NPAHBBLRKXZJLI-UHFFFAOYSA-N 651832 US20240051954, Example 44::6-chloro-2-(5-(1,2-dimethoxy- ethyl)-4H-1,2,4-triazol-3-yl)- 5-methoxy-1-methyl-3-(1H- pyrazol-4-yl)-1H-pyrrolo[3,2- b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 77.0 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651832 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651832&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362558 494495990 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376247 COc1nc2c(c(-c3nnc([nH]3)C(F)(F)F)n(C)c2cc1Cl)-n1ccnc1 InChI=1S/C15H11ClF3N7O/c1-25-8-5-7(16)13(27-2)21-9(8)10(26-4-3-20-6-26)11(25)12-22-14(24-23-12)15(17,18)19/h3-6H,1-2H3,(H,22,23,24) LLQGUURJMXHPFB-UHFFFAOYSA-N 651833 US20240051954, Example 45::6-chloro-3-(1H-imidazol-1-yl)- 5-methoxy-1-methyl-2-(5- (trifluoromethyl)-4H-1,2,4- triazol-3-yl)-1H-pyrrolo[3,2- b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 384 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651833 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651833&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549081 494495991 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376248 COc1nc2c(c([nH]c2cc1Cl)-c1nnc([nH]1)C(F)(F)F)-n1ccnc1 InChI=1S/C14H9ClF3N7O/c1-26-12-6(15)4-7-8(21-12)10(25-3-2-19-5-25)9(20-7)11-22-13(24-23-11)14(16,17)18/h2-5,20H,1H3,(H,22,23,24) YZCGIVPAQVYPPB-UHFFFAOYSA-N 651834 US20240051954, Example 46::6-chloro-3-(1H-imidazol-1-yl)- 5-methoxy-2-(5-(trifluoro- methyl)-4H-1,2,4-triazol-3-yl)- 1H-pyrrolo[3,2-b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 80.0 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651834 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651834&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549074 494495992 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376249 COc1nc2c(-c3cn[nH]c3)c([nH]c2cc1Cl)-c1nnc([nH]1)C(F)(F)F InChI=1S/C14H9ClF3N7O/c1-26-12-6(15)2-7-9(22-12)8(5-3-19-20-4-5)10(21-7)11-23-13(25-24-11)14(16,17)18/h2-4,21H,1H3,(H,19,20)(H,23,24,25) QUQHBWRRHNFHCF-UHFFFAOYSA-N 651835 US20240051954, Example 47::6-chloro-5-methoxy-3-(1H- pyrazol-4-yl)-2-(5-(trifluoro- methyl)-4H-1,2,4-triazol-3-yl)- 1H-pyrrolo[3,2-b]pyridine Cyclic GMP-AMP synthase [147-522] Homo sapiens 91.0 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651835 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651835&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362559 494495993 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376250 Oc1nc2c(c([nH]c2cc1Cl)-c1nnc([nH]1)C(F)(F)F)-n1ccnc1 InChI=1S/C13H7ClF3N7O/c14-5-3-6-7(20-11(5)25)9(24-2-1-18-4-24)8(19-6)10-21-12(23-22-10)13(15,16)17/h1-4,19H,(H,20,25)(H,21,22,23) SUKUHGXDLCWQHM-UHFFFAOYSA-N 651836 US20240051954, Example 48::6-chloro-3-(1H-imidazol-1-yl)- 2-(5-(trifluoromethyl)-4H- 1,2,4-triazol-3-yl)-1H-pyrrolo- [3,2-b]pyridin-5-ol Cyclic GMP-AMP synthase [147-522] Homo sapiens 7585 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651836 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651836&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549053 494495994 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376251 Oc1nc2c(-c3cn[nH]c3)c([nH]c2cc1Cl)-c1nnc([nH]1)C(F)(F)F InChI=1S/C13H7ClF3N7O/c14-5-1-6-8(21-11(5)25)7(4-2-18-19-3-4)9(20-6)10-22-12(24-23-10)13(15,16)17/h1-3,20H,(H,18,19)(H,21,25)(H,22,23,24) MZFMNJAEZYPVLW-UHFFFAOYSA-N 651837 US20240051954, Example 49::6-chloro-3-(1H-pyrazol-4-yl)- 2-(5-(trifluoromethyl)-4H- 1,2,4-triazol-3-yl)-1H-pyrrolo- [3,2-b]pyridin-5-ol Cyclic GMP-AMP synthase [147-522] Homo sapiens 294 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651837 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651837&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362560 494495995 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376252 Cn1c(-c2nnc([nH]2)C(F)(F)F)c(-c2cn[nH]c2)c2nc(O)c(Cl)cc12 InChI=1S/C14H9ClF3N7O/c1-25-7-2-6(15)12(26)21-9(7)8(5-3-19-20-4-5)10(25)11-22-13(24-23-11)14(16,17)18/h2-4H,1H3,(H,19,20)(H,21,26)(H,22,23,24) HHZOYUOIJKGBIF-UHFFFAOYSA-N 651838 US20240051954, Example 50::6-chloro-1-methyl-3-(1H- pyrazol-4-yl)-2-(5-(trifluoro- methyl)-4H-1,2,4-triazol-3-yl)- 1H-pyrrolo[3,2-b]pyridin-5-ol Cyclic GMP-AMP synthase [147-522] Homo sapiens 741 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651838 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651838&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 171362561 494495996 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45 1376253 COc1nc2c(c(-c3nnc(CN(C)C)[nH]3)n(C)c2cc1Cl)-n1ccnc1 InChI=1S/C17H19ClN8O/c1-24(2)8-12-20-16(23-22-12)15-14(26-6-5-19-9-26)13-11(25(15)3)7-10(18)17(21-13)27-4/h5-7,9H,8H2,1-4H3,(H,20,22,23) YIFGXPQLMJOZCE-UHFFFAOYSA-N 651839 US20240051954, Example 51::1-(5-(6-chloro-3-(1H-imidazol- 1-yl)-5-methoxy-1-methyl-1H- pyrrolo[3,2-b]pyridin-2-yl)- 4H-1,2,4-triazol-3-yl)-N,N- dimethylmethanamine Cyclic GMP-AMP synthase [147-522] Homo sapiens 308 US Patent 10.7270/Q27H1PRG aid1963387 US20240051954 CARCACHE, D; GRUBER, F; GUERINI, D; GUNZENHAUSER, M; HENG, R; PERRUCCIO, F; SIMIC, O; SPANKA, C 2/15/2024 4/23/2024 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=651839 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1547&target=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=651839&enzyme=Cyclic+GMP-AMP+synthase+%5B147-522%5D&column=ki&startPg=0&Increment=50&submit=Search 164549010 494495997 1 PVSAPILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF 4O68,6EDB,8SJ8,8SI0,8SHZ,4KM5,9LIO,9J2Y,9J2X,9J2W,8IMG,8IMF,8IME,7CCR,7CCQ,6LRL,6LRK,6LRJ,6LRI,6LRE,6LRC,4LEW,4LEV,6EDC,9MDC,9ELX,7FUP,7FTX,5VDW,5VDV,5VDU,5VDT,5VDS,5VDR,5VDQ,5VDP,5VDO,4O69,4O67,7FUR,7FUQ,7FUO,7FUN,7FUM,7FUL,7FUK,7FUJ,7FUI,7FUH,7FUG,7FUF,7FUE,7FUD,7FUC,7FUB,7FUA,7FU9,7FU8,7FU7,7FU6,7FU5,7FU4,7FU3,7FU2,7FU1,7FU0,7FTZ,7FTY,7FTW,7FTV,7FTU,7FTT,7FTS,7FTR,7FTQ,7FTP,7FTO,7FTM,7FTL,7FTK,7FTJ,7FTI,7FTH,7FTG,7FTF,6NFO,6NFG,6NAO,5V8O Cyclic GMP-AMP synthase CGAS_HUMAN Q8N884 L0L2J9 Q14CV6 Q32NC9 Q5SWL0 Q5SWL1 Q96E45